On Friday, August 22nd, the U. S. Drug Enforcement Administration (DEA) published a Final Rule moving hydrocodone combination products (HCPs) from Schedule III to the more-restrictive Schedule II. This Final Rule imposes the regulatory controls and sanctions applicable to Schedule II substances on those who handle or propose to handle HCPs. The rule goes into effect 45 days from its publish date.
More Latest News
August 29, 2019
Under a State of Emergency, a pharmacist, in his or her professional judgment, may be able to refill prescriptions early. Continue reading
August 23, 2019
The Quarterly Performance Report for the fourth quarter of the 2018-2019 fiscal year is now available online. Continue reading